reference/33121740

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33121740

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	993
issn	1369-6998 1941-837X
issueIdentifier	10
pageRange	981-993
publicationName	Journal of Medical Economics
startingPage	981
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e6db44f2ea14f83bf5a8f92d381d2228
bibliographicCitation	Bensimon AG, Zhou Z, Jenkins M, Song Y, Gao W, Signorovitch J, Krepler C, Liu FX, Wang J, Aguiar-Ibáñez R. Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States. Journal of Medical Economics. 2019 May 17;22(10):981–93. doi: 10.1080/13696998.2019.1609485.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_035d18135e405d2bec02d1237c39e513 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e96bd3fcddedb3079444198c7fb0b698 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86640082a6c7c8995f5d3af887c0f011 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05110da2b46d93d6f636169e4d709060 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e83f37fad3faddd57d25f3ad10d54005 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3dc580213e6c51006305c0f25d54dae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22d9e9e1b29d0158e657a7c0dc923c22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_332dddfd39339f90d5968df7ef4437f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f0bdb0688a4b4175c00072b87ae7c7b
date	2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/31012765 https://doi.org/10.1080/13696998.2019.1609485
isPartOf	https://portal.issn.org/resource/ISSN/1941-837X https://portal.issn.org/resource/ISSN/1369-6998 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35742
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States
discusses	http://id.nlm.nih.gov/mesh/M000626416 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0586473
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008545Q000473 http://id.nlm.nih.gov/mesh/D012878Q000188 http://id.nlm.nih.gov/mesh/D003362 http://id.nlm.nih.gov/mesh/D008545Q000188 http://id.nlm.nih.gov/mesh/D000074322Q000191 http://id.nlm.nih.gov/mesh/D061067Q000191 http://id.nlm.nih.gov/mesh/D012878Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000096142 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000074322Q000008 http://id.nlm.nih.gov/mesh/D009364 http://id.nlm.nih.gov/mesh/D061067Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008390 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D014481
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Total number of triples: 53.